Fierce Pharma

FEBRUARY 7, 2023

Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics fkansteiner Tue, 02/07/2023 - 10:08

Government 307

Government 307

Clarivate

FEBRUARY 9, 2023

After many months of planning, we are launching the Preprint Citation Index , a multidisciplinary collection of preprints from leading repositories that helps researchers stay current with the newest research while maintaining confidence in the resources they rely on. With the launch of the Preprint Citation Index , we are making it even easier for researchers to include preprints in their existing research workflows.

Leads 145

Leads Government Management 145

Medgadget

FEBRUARY 7, 2023

Engineers at the University of California San Diego have developed a wearable ultrasound system for cardiac imaging. The postage stamp-sized patch can be worn on the skin of the chest and uses AI and ultrasound waves to perform advanced imaging of the heart. The technology can even be worn to perform cardiac ultrasound imaging during exercise. Each patch can be worn for up to 24 hours, and provides information on how much blood the heart is pumping, a key metric in detecting and appraising a var

Engineering 129

Engineering Leads 129

European Pharmaceutical Review

FEBRUARY 7, 2023

A wave of important legislative changes is anticipated in the EU in 2023 making this year one of the biggest for the EU regulatory landscape governing the life sciences industry in recent times. Changes have been spurred by the COVID-19 pandemic, which emphasised the need to urgently modernise outdated EU pharmaceutical law and revise regulatory ambitions in the MedTech sector.

Medical 117

Medical Government Marketing Medicine 117

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

FEBRUARY 8, 2023

Novartis, Bayer marshal relief for Turkey and Syria following devastating earthquake fkansteiner Wed, 02/08/2023 - 09:56

261

261

MedCity News

FEBRUARY 7, 2023

Virta is available this month to all Blue Shield of California members enrolled in preferred provider organization plans for individual and family, fully insured, self funded and Medicare Advantage. The payer has been working with Virta since 2019 when the digital health company joined Blue Shield of California’s Wellvolution, a platform of digital lifestyle apps.

Networking 121

Networking Insurance 121

European Pharmaceutical Review

FEBRUARY 10, 2023

Changes to management for Big Pharma companies Astellas and Bayer AG have been announced for 2023. Astellas Astellas Pharma Inc. has approved changes of its Representative Director, President and CEO and its management structure. Effective April 1, 2023, Naoki Okamura and Kenji Yasukawa will hold the following positions: Naoki Okamura is currently Representative Director, Executive Vice President of Astellas.

Management 105

Management Engineering Pharma Leads 105

Fierce Pharma

FEBRUARY 8, 2023

BREAKING: Bayer taps Roche vet Anderson as its next CEO, pushing out Baumann esagonowsky Wed, 02/08/2023 - 11:28

287

287

MedCity News

FEBRUARY 7, 2023

Francesca de Quesada Covey, chief investment officer at investment firm TheVentureCity, believes the women’s health sector will come into its own in the next few years. She said startups focused on improving care delivery will probably have the easiest time raising funds of all the companies in the femtech space.

115

115

Pharmaceutical Technology

FEBRUARY 7, 2023

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Takeda ’s dengue virus vaccine candidate, Qdenga (Dengue Tetravalent Vaccine [Live, Attenuated]). The vaccine candidate has been approved for active immunisation against the infection in people from four years of age. Qdenga has been developed based on a live-attenuated dengue serotype 2 virus that offers the genetic backbone for four dengue virus serotypes.

Safety 105

Safety Medicine Healthcare Healthcare 105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

European Pharmaceutical Review

FEBRUARY 9, 2023

Researchers have shown that a newly developed two-chamber setup (TCS) for containment investigations consisting of an emission and a detection chamber may predict highly potent active pharmaceutical ingredient (HPAPI) dustiness in a sealed system at different flow conditions. These different flow conditions include the plain diffusive transport and the diffusive transport with the oppositely directed convective flow of airborne particles of the safe surrogate substance acetaminophen (ACAM).

Transportation 105

Transportation Specialization Distribution Manufacturing 105

Fierce Pharma

FEBRUARY 9, 2023

Docs likely to be 'cautious' when prescribing GSK's first-in-class anemia drug Jesduvroq, survey finds fkansteiner Thu, 02/09/2023 - 14:18

243

243

MedCity News

FEBRUARY 8, 2023

High prices have drawn other critics, as well, including President Joe Biden. He renewed his call for a broad price cap during his annual State of the Union address. Pharma companies insist they have been part of the solution.

Pharma 106

Pharma 106

Pharmaceutical Technology

FEBRUARY 5, 2023

The US Food and Drug Administration (FDA) has granted approval for Gilead Sciences ’ Trodelvy (sacituzumab govitecan-hziy) to treat unresectable locally advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative (IHC 0, IHC 1+ or IHC 2+/ISH–) breast cancer adult patients. Trodelvy has been approved for HR+/HER2- breast cancer adult patients who have previously received endocrine-based therapy and a minimum of two additional systemic therapies

Food and Drug Administration 105

Food and Drug Administration FDA Physicians Food 105

Advertisement

European Pharmaceutical Review

FEBRUARY 7, 2023

The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to RP-A501, an adeno-associated virus (AAV)-based gene therapy for Danon disease. “RP-A501 is the first cardiac gene therapy to receive RMAT designation from the FDA,” commented Dr Gaurav Shah, Chief Executive Officer at Rocket Pharmaceuticals.

Food and Drug Administration 105

Food and Drug Administration FDA Medicine Food 105

Fierce Pharma

FEBRUARY 9, 2023

Eli Lilly's employment decisions under fire once again as sales rep lodges age discrimination claim zbecker Thu, 02/09/2023 - 14:45

Sales 243

Sales 243

MedCity News

FEBRUARY 8, 2023

Suicide-related diagnoses in children and adolescents increased 14% since before the pandemic, a new Evernorth analysis shows. Female and Asian/Pacific Islander youth are especially struggling.

108

108

Pharmaceutical Technology

FEBRUARY 8, 2023

On February 7, at a town hall organised to discuss clinical trial designs for gene therapies, FDA experts pushed pharma players to look for ways to establish clinical effectiveness despite the challenges in recruiting patients with rare diseases. In 2020, the FDA released a guidance document for the industry with recommendations for sponsors developing gene therapies for rare diseases.

FDA 105

FDA Patients Pharmacology Pharmaceutical 105

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

European Pharmaceutical Review

FEBRUARY 10, 2023

The Cell and Gene Therapy Catapult (CGT Catapult) has announced its involvement in the development of a major new campus for life science businesses in Stevenage, Hertfordshire. This announcement follows news from July 2022 of an intended £900m joint venture investment by two property firms, to develop a new life sciences campus in Stevenage. The new campus extension will deliver one of the largest campuses of its kind in the UK and Europe.

Manufacturing 98

Manufacturing Leads Medicine Healthcare 98

Fierce Pharma

FEBRUARY 8, 2023

Biden takes aim at pharma in SOTU speech, vowing to defend IRA from repeal efforts kdunleavy Wed, 02/08/2023 - 10:38

Pharma 246

Pharma 246

MedCity News

FEBRUARY 10, 2023

The power of digital health in helping people manage pain is clear, yet it remains untapped potential. All the players, from digital health vendors to payers and providers, need to work together to make it a scalable reality.

Management 102

Management 102

Pharmaceutical Technology

FEBRUARY 6, 2023

Researchers at the Feinstein Institutes for Medical Research have discovered a new protein that can be a potential therapeutic target for lethal sepsis. Led by Feinstein Institutes researcher Haichao Wang, the new study focuses on detecting protein mediators that might contribute to uncontrolled immune responses to lethal infections. It explores the monoclonal antibody detection that may work against procathepsin-L (pCTS-L), a pro-inflammatory protein mediator, as the potential remedy.

Medical 105

Medical Medicine Patients Pharmaceutical 105

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Pharmaceutical Commerce

FEBRUARY 9, 2023

As the range of treatment options for rheumatoid arthritis (RA) continues to grow and biosimilars are poised to enter the arena, the need for expert strategies to improve therapy selection and address the access, affordability, and adherence challenges patients face is coming into sharper focus.

Patients 98

Patients 98

Fierce Pharma

FEBRUARY 9, 2023

Galapagos' Jyseleca flops phase 3 Crohn's study, dealing another blow to troubled JAK inhibitor zbecker Thu, 02/09/2023 - 09:56

240

240

MedCity News

FEBRUARY 7, 2023

Employers are most interested in switching up their vendor partners for wellbeing programs, the Willis Towers Watson survey found. About 55% of respondents said they will make changes to their wellbeing vendor partners in 2023 or 2024, while 12% already did in 2022.

109

109

Pharmaceutical Technology

FEBRUARY 10, 2023

AbbVie has reported full-year 2022 net revenues of $58.054bn, representing a 3.3% rise on a reported basis and 5.1% on an operational basis. The company reported an increase of 1.6% on a reported basis in global net revenues to $15.121bn for the fourth quarter (Q4) of 2022. For the full-year, worldwide net revenues from the Immunology portfolio stood at $28.924bn, increasing 14.4% on a reported basis.

Pharmaceutical 98

Pharmaceutical 98

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

European Pharmaceutical Review

FEBRUARY 8, 2023

Research from data and analytics company GlobalData shows that the use of CD19 chimeric antigen receptor T-cell (CAR-T) agents for blood cancer is set to significantly increase between 2021-2031. GlobalData predicts Bristol-Myers Squibb’s Breyanzi and Gilead’s Yescarta are set to have high annual sales in the forecast period. CD19 CAR-T agents Sam Warburton, Oncology Analyst at GlobalData explained: “the clinical and commercial landscape of CD19 CAR-T agents is expected to dramatically change ov

Marketing 98

Marketing Sales Physicians Patients 98

Fierce Pharma

FEBRUARY 7, 2023

Eisai starts clock ticking on approval filing for subcutaneous sibling to Alzheimer's drug Leqembi ntaylor Tue, 02/07/2023 - 08:59

236

236

MedCity News

FEBRUARY 9, 2023

Allurion Technologies has developed a gastric balloon that does not require surgery. The merger deal taking Allurion public comes as the company continues global commercialization of its technology.

Biopharma 102

Biopharma Medical 102

Copyright Clearance Center

FEBRUARY 7, 2023

February 7, 20 23 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, has earned a 2023 Top Workplaces USA national award from Energage , a purpose-driven organization that develops solutions to build and brand Top Workplaces. This employer recognition program recognizes companies with 150 or more employees across the country that have built great workplace cultures.

Marketing 98

Marketing 98

Advertisement

Distribution